Want to join the conversation?
$CNX sold an aggregate $5.8Bil of assets starting from 2012, paid in the form of cash, royalty streams and the assumption of liabilities. The company said that it will not sell assets at depressed prices based on internal view of NAV per share weighted against sale proceeds opportunities.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.